From Which VCs Are Poised to Profit From the Biotech IPO Boom?:

Beth Seidenberg of Kleiner Perkins Caufield &  Byers
Beth Seidenberg of Kleiner Perkins Caufield & Byers

Beth Seidenberg of Kleiner Perkins Caufield & Byers